Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Sarah Harman
Preclinical Evaluation of the HIV-1 Fusion Inhibitor L'644 as a Potential Candidate Microbicide
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Related publications
Punica Granatum(Pomegranate) Juice Provides an HIV-1 Entry Inhibitor and Candidate Topical Microbicide
BMC Infectious Diseases
Infectious Diseases
Non-Aqueous Silicone Elastomer Gels as a Vaginal Microbicide Delivery System for the HIV-1 Entry Inhibitor Maraviroc
Journal of Controlled Release
Pharmaceutical Science
Inhibition of Human Immunodeficiency Virus Type 1 Infection by the Candidate Microbicide Dapivirine, a Nonnucleoside Reverse Transcriptase Inhibitor
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
L-696,474, a Novel Cytochalasin as an Inhibitor of HIV-1 Protease. III. Biological Activity.
Journal of Antibiotics
Drug Discovery
Pharmacology
Peptides and Peptidomimetics as Tools to Probe Protein-Protein Interactions – Disruption of HIV-1 Gp41 Fusion Core and Fusion Inhibitor Design
The Inhibitor Apoptosis Protein Antagonist Debio 1143 Is an Attractive HIV-1 Latency Reversal Candidate
PLoS ONE
Multidisciplinary
Enfuvirtide, an HIV-1 Fusion Inhibitor, for Drug-Resistant HIV Infection in North and South America
New England Journal of Medicine
Medicine
Homeostatic Properties of Lactobacillus Jensenii Engineered as a Live Vaginal Anti-Hiv Microbicide
BMC Microbiology
Microbiology
Identification of GSK3186899/DDD853651 as a Preclinical Development Candidate for the Treatment of Visceral Leishmaniasis
Journal of Medicinal Chemistry
Drug Discovery
Molecular Medicine